Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Statistics

Total Valuation

BNTC has a market cap or net worth of $340.99 million. The enterprise value is $238.37 million.

Market Cap	340.99M
Enterprise Value	238.37M

Important Dates

The next estimated earnings date is Thursday, September 25, 2025, before market open.

Earnings Date	Sep 25, 2025
Ex-Dividend Date	n/a

Share Statistics

BNTC has 26.25 million shares outstanding. The number of shares has increased by 46.71% in one year.

Current Share Class	26.25M
Shares Outstanding	26.25M
Shares Change (YoY)	+46.71%
Shares Change (QoQ)	+74.85%
Owned by Insiders (%)	5.77%
Owned by Institutions (%)	46.18%
Float	12.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.40
P/TBV Ratio	3.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.80, with a Debt / Equity ratio of 0.01.

Current Ratio	14.80
Quick Ratio	14.74
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.57% and return on invested capital (ROIC) is -34.13%.

Return on Equity (ROE)	-48.57%
Return on Assets (ROA)	-31.34%
Return on Invested Capital (ROIC)	-34.13%
Return on Capital Employed (ROCE)	-30.69%
Revenue Per Employee	n/a
Profits Per Employee	-$1.66M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.98% in the last 52 weeks. The beta is 0.40, so BNTC's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+44.98%
50-Day Moving Average	12.67
200-Day Moving Average	12.48
Relative Strength Index (RSI)	58.50
Average Volume (20 Days)	43,150

Short Selling Information

Short Interest	1.43M
Short Previous Month	1.44M
Short % of Shares Out	5.46%
Short % of Float	11.13%
Short Ratio (days to cover)	14.71

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-30.14M
Pretax Income	-21.69M
Net Income	-26.49M
EBITDA	-30.06M
EBIT	-30.14M
Earnings Per Share (EPS)	-$1.47

Balance Sheet

The company has $103.58 million in cash and $959,000 in debt, giving a net cash position of $102.62 million or $3.91 per share.

Cash & Cash Equivalents	103.58M
Total Debt	959,000
Net Cash	102.62M
Net Cash Per Share	$3.91
Equity (Book Value)	97.57M
Book Value Per Share	3.82
Working Capital	96.98M

Cash Flow

In the last 12 months, operating cash flow was -$18.67 million and capital expenditures -$18,000, giving a free cash flow of -$18.69 million.

Operating Cash Flow	-18.67M
Capital Expenditures	-18,000
Free Cash Flow	-18.69M
FCF Per Share	-$0.71

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BNTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-46.71%
Shareholder Yield	-46.71%
Earnings Yield	-7.77%
FCF Yield	-5.48%

Analyst Forecast

The average price target for BNTC is $26.00, which is 100.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$26.00
Price Target Difference	100.15%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 26, 2023. It was a reverse split with a ratio of 1:17.

Last Split Date	Jul 26, 2023
Split Type	Reverse
Split Ratio	1:17

Scores

Altman Z-Score	n/a
Piotroski F-Score	2